| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |